Hübner F, Recke A, Zillikens D, Linder R, Schmidt E. Prevalence and Age Distribution of Pemphigus and Pemphigoid Diseases in Germany. J Invest Dermatol. 2016 Jul 25. pii: S0022-202X(16)32122-4.
Koga H, Recke A, Vidarsson G, Pas HH, Jonkman MF, Hashimoto T, Kasprick A, Ghorbanalipoor S, Tenor H, Zillikens D, Ludwig RJ. PDE4 Inhibition as Potential Treatment of Epidermolysis Bullosa Acquisita. J Invest Dermatol. 2016 Jul 5. pii: S0022-202X(16)32095-4.
Müller S, Behnen M, Bieber K, Möller S, Hellberg L, Witte M, Hänsel M, Zillikens D, Solbach W, Laskay T, Ludwig RJ. Dimethylfumarate Impairs Neutrophil Functions. J Invest Dermatol. 2016 Jan;136(1):117-26.
Kasperkiewicz M, Sadik CD, Bieber K, Ibrahim SM, Manz RA, Schmidt E, Zillikens D, Ludwig RJ. Epidermolysis Bullosa Acquisita: From Pathophysiology to Novel Therapeutic Options. J Invest Dermatol. 2016 Jan;136(1):24-33.
Lemcke S, Sokolowski S, Rieckhoff N, Buschtez M, Kaffka C, Winter-Keil A, Schaller C, Rottmann N, Sadik CD, Stöcker W, Zillikens D, Schmidt E. Automated direct immunofluorescence analyses of skin biopsies. J Cutan Pathol. 2016 Mar;43(3):227-35.
Ellebrecht CT, Srinivas G, Bieber K, Banczyk D, Kalies K, Künzel S, Hammers CM, Baines JF, Zillikens D, Ludwig RJ, Westermann J. Skin microbiota-associated inflammation precedes autoantibody induced tissue damage in experimental epidermolysis bullosa acquisita. J Autoimmun. 2016 Apr;68:14-22.
Iwata H, Witte M, Samavedam UK, Gupta Y, Shimizu A, Ishiko A, Schröder T, Seeger K, Dahlke M, Rades D, Zillikens D, Ludwig RJ. Radiosensitive Hematopoietic Cells Determine the Extent of Skin Inflammation in Experimental Epidermolysis Bullosa Acquisita.J Immunol. 2015 Sep 1;195(5):1945-54
Sadeghi H, Lockmann A, Hund AC, Samavedam UK, Pipi E, Vafia K, Hauenschild E, Kalies K, Pas HH, Jonkman MF, Iwata H, Recke A, Schön MP, Zillikens D, Schmidt E, Ludwig RJ. Caspase-1-independent IL-1 release mediates blister formation in autoantibody-induced tissue injury through modulation of endothelial adhesion molecules. J Immunol. 2015 Apr 15;194(8):3656-63
Vorobyev A, Ujiie H, Recke A, Buijsrogge JJ, Jonkman MF, Pas HH, Iwata H, Hashimoto T, Kim SC, Hoon Kim J, Groves R, Samavedam U, Gupta Y, Schmidt E, Zillikens D, Shimizu H, Ludwig RJ. Autoantibodies to Multiple Epitopes on the Non-Collagenous-1 Domain of Type VII Collagen Induce Blisters. J Invest Dermatol. 2015 Jun;135(6):1565-73
Kasprick A, Yu X, Scholten J, Hartmann K, Pas HH, Zillikens D, Ludwig RJ, Petersen F. Conditional depletion of mast cells has no impact on the severity of experimental epidermolysis bullosa acquisita. Eur J Immunol. 2015 May;45(5):1462-70
Kasperkiewicz M, Schulze F, Meier M, van Beek N, Nitschke M, Zillikens D, Schmidt E. Treatment of bullous pemphigoid with adjuvant immunoadsorption: a case series. J Am Acad Dermatol. 2014 Nov;71(5):1018-20
Kasperkiewicz M, Süfke S, Schmidt E, Zillikens D. IgE-specific immunoadsorption for treatment of recalcitrant atopic dermatitis. JAMA Dermatol. 2014 Dec;150(12):1350-1
Ludwig RJ, Borradori L, Diaz LA, Hashimoto T, Hertl M, Ibrahim SM, Jonkman MF, Kitajima Y, Murrell DF, Schmidt E, Shimizu H, Stanley JR, Woodley DT, Zillikens D. From epidemiology and genetics to diagnostics, outcome measures, and novel treatments in autoimmune bullous diseases. J Invest Dermatol. 2014 Sep;134(9):2298-300
Schulze FS, Beckmann T, Nimmerjahn F, Ishiko A, Collin M, Köhl J, Goletz S, Zillikens D, Ludwig R, Schmidt E. Fcγ receptors III and IV mediate tissue destruction in a novel adult mouse model of bullous pemphigoid. Am J Pathol. 2014 Aug;184(8):2185-96.
Recke A, Trog LM, Pas HH, Vorobyev A, Abadpour A, Jonkman MF, van Zandbergen G, Kauderer C, Zillikens D, Vidarsson G, Ludwig RJ. Recombinant human IgA1 and IgA2 autoantibodies to type VII collagen induce subepidermal blistering ex vivo. J Immunol. 2014 Aug 15;193(4):1600-8.
Ein vollständige Liste finden Sie unter der Researcher ID oder bei Pubmed.